FTC sues significant pharmacy reward professionals around insulin rates The company brought motion towards Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the record cost of existence-conserving insulin medicines. Sanders swiftly condemned the go in a statement Wednesday, noting he was let down https://kethek.com/